Mariela Sivina - Concepedia

Author

Mariela Sivina

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

M Sivina, M. Sivina, Mariela Sivina

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Dana-Farber Cancer Institute Broad Institute University of California San Diego National Institutes of Health

About

Mariela Sivina is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	725
2	Cell Biology	9	9	704
3	Immunology	9	9	568
4	Pathology	4	4	314
5	Autoimmunity	4	4	147

Mariela Sivina

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
The phosphoinositide 3′-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia Julia Hoellenriegel, Sarah Meadows, Mariela Sivina, Blood	2011	547
Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition Jan A. Burger, Dan A. Landau, Amaro Taylor‐Weiner, Nature Communications	2016	338
Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance Antonina V. Kurtova, Kumudha Balakrishnan, Rong Chen, Blood	2009	315
B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406 Maite P. Quiroga, Kumudha Balakrishnan, Antonina V. Kurtova, Blood	2009	238
Randomized trial of ibrutinib vs ibrutinib plus rituximab in patients with chronic lymphocytic leukemia Jan A. Burger, Mariela Sivina, Nitin Jain, Blood	2018	219
The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy Dan A. Landau, Clare Sun, Daniel Rosebrock, Nature Communications	2017	173
Lenalidomide as initial therapy of elderly patients with chronic lymphocytic leukemia Xavier C. Badoux, Michael J. Keating, Sijin Wen, Blood	2011	164
The transcription factor MEF/ELF4 regulates the quiescence of primitive hematopoietic cells H. Daniel Lacorazza, Takeshi Yamada, Yan Liu, Cancer Cell Transcriptional RegulationCell RegulationCell DivisionGeneticsCellular Senescence	2006	157
Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migration Julia Hoellenriegel, Greg Coffey, Uma Sinha, Leukemia Hematological MalignancyLymphoid NeoplasiaReceptor Tyrosine KinaseImmunologyAdult T-cell Leukemia-lymphoma	2012	138
Molecular map of chronic lymphocytic leukemia and its impact on outcome Binyamin A. Knisbacher, Ziao Lin, Cynthia K. Hahn, Nature Genetics Hematological MalignancyLymphoid NeoplasiaOncologyChronic Lymphocytic LeukemiaMolecular Map	2022	135

Page 1